Sintx Technologies has earned FDA 510(k) clearance for its SINAPTIC Foot & Ankle Osteotomy Wedge System.
The implant system combines a silicon nitride biomaterial, surgeon-informed implant designs and a single-use instrument kit, according to an Oct. 20 news release from the company.
Sintx aims to increase surgical efficiency, precision and predictability with its implant system.
The company is planning a U.S. commercial launch in the first quarter of 2026, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
